drugset / Trial / NCT03191903
Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multi-center, randomized, double-blind, parallel group, active comparator controlled trial to evaluate the efficacy and safety of a single injection of Cingal for the relief of joint pain in subjects with OA of the knee.
Timeline
- Start
- 2017-05-25
- Primary completion
- 2018-04-23
- Completion
- 2018-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 88 mg | Other |
| Comparator | Triamcinolone Hexacetonide | Other / unclassified | 18 mg | Other |
| Comparator | Triamcinolone Hexacetonide | Other / unclassified | 20 mg | Other |